ArticleScientific reports2025
Artificial intelligence improves detection and classification of pulmonary venous hypertension related to left ventricular diastolic dysfunction by chest radiography.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence in Cardiovascular Medicine: Focus on Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026Pooled it
- AI-enabled chest x-ray potentially detects subclinical diastolic dysfunction in diabesity and monitors its functional responses to GLP-1 or GLP-1/GIP receptor agonists: initial exploration and proof-of-concept.Cardiovascular diabetology. Endocrinology reports · 2026Article
- Artificial Intelligence in Pulmonary Hypertension: Current State and Future Prospects.Reviews in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Isolated-Left Ventricular Diastolic Dysfunction [LVDD] ranges (and may progress) from preclinical asymptomatic, symptomatic-LVDD, to LVDD-predominate Heart Failure [HF] presentations; if recognized early, LVDD progression might be preventable. Current early-HF screening remains limited, providing opportunities for insights from a standard Chest X-Ray [CXR]. While CXR assessment for "pulmonary congestion" supports suspected-HF evaluation in evidence-based guidelines, the potential for systematic Pulmonary Venous Hypertension [PVH]-Staging to contribute to initial detection and scaling of LVDD is unclear. This study compared CXR-based PVH-Staging to Doppler Echocardiography [DEcho]-based LVDD-Grading in the absence of systolic dysfunction. Questions included: (1) With PVH-Staging performed by cardiothoracic radiologists, what intra-/inter-reader variabilities remain? (2) Does PVH-Staging track LVDD-Grading? and (3) Can AI-assisted PVH prediction of LVDD-Grade match human performance? CXR examinations of 1,682 (including 750 asymptomatic/healthy) subjects, without: (1) Anatomical/physiological confounders of DEcho or CXR examinations (≤ 24 h apart), and (2) AI model-training confounders, were independently assigned 1 of 11 (9 PVH-related) Pulmonary Vasculature Patterns [PVPs] by 4 cardiothoracic radiologists and repeated for reliability evaluation. Expert-consensus Human Ground Truth [HGT] PVH PVPs were correlated with LVDD Grades (0 to 3-4), as were PVH-Rank predictions by a transformer-based AI model ["PVPI"]. Despite experience-dependent intra-/inter-reader reliability in PVP assignment, there was significant (p < 0.001) overall consistency. With increasing HGT PVH Stage, a significant (p < 0.001) trend towards increasing LVDD Grade was found; while PVH-Staging achieved confidence backing Grade 0/No LVDD, confident LVDD Grade recognition was not achieved until Grades 3-4/Restrictive Filling. However, a significantly (p < 0.001) stronger incrementally positive trend in PVPI PVH-Ranking with LVDD-Grading was demonstrated. Although validated, PVH-Staging for LVDD-Grading is limited by reader variabilities. AI-assisted PVH-Ranking may facilitate earlier and widespread objective CXR screening for LVDD which is ubiquitous in HF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.